Clinical Trial Update: Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias

View source ↗

Summary

An NCI-sponsored pilot prospective study evaluates PET-CT imaging in participants with relapsed/refractory B-cell acute lymphoblastic leukemia; the trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: B Cell, Acute Lymphoblastic Leukemia | Status: COMPLETED